The Westminster lensArchive · Written questions · 4,527 tabled · 4,280 answered

Written questions by Obese-Jecty.

Every parliamentary written question tabled by Ben Obese-Jecty this session, with the full answer and department. Back to the MP page.

Department:All (4,527)Ministry of Defence (2243)Home Office (575)Department for Science, Innovation and Technology (246)Department of Health and Social Care (193)Ministry of Justice (177)Foreign, Commonwealth and Development Office (158)Ministry of Housing, Communities and Local Government (136)Cabinet Office (134)Department for Education (111)Department for Environment, Food and Rural Affairs (104)Department for Energy Security and Net Zero (100)Department for Transport (97)

Showing 321340 of 4,527 · this parliament

← PreviousPage 17 of 227Next →
15 Apr 2026·Ministry of Defence·Answered
Asked

How much of the proposed in-year savings from his Department for 2025/26 were carried forward for inclusion within 2026/27 projected in-year savings.

Reply

As part of normal good financial management, the Ministry of Defence continues to allocate resources effectively to meet departmental and operational priorities. The Department's final position for 2025-26 will be set out in the Annual Report and Accounts.

15 Apr 2026·Treasury·Answered
Asked

Whether she plans to review the operation of the merged R&D tax relief scheme in relation to companies providing pre-clinical research services.

Reply

The Government recognises the important role that life sciences research and development (R&D) plays in driving innovation and economic growth as well as the benefits it can bring for society. The Government committed to maintaining the generosity of the rates in both the merged R&D Expenditure Credit (RDEC) scheme and the Enhanced R&D Intensive Support (ERIS). This, combined with the commitment to cap the headline rate of Corporation Tax, means that companies doing qualifying R&D – including pre-clinical R&D – will continue to receive between £15 to £27 for every £100 spent on R&D.Under the merged R&D scheme, relief is generally available to the company that decides to undertake R&D and bears the financial risk, rather than the company contracted to carry it out, subject to limited exceptions. This approach is intended to ensure support is targeted at the company that invests in the R&D. These rules apply to pre-clinical research services in the same way as they do for all other companies.

15 Apr 2026·Treasury·Answered
Asked

What is the methodology and the formula used in the current rateable value calculation.

Reply

The Valuation Office calculates a rateable value for each business property in England and Wales. A rateable value is an estimate of what it would cost to rent a property for a year, on a set date known as the Valuation Date.The methodology and approach used to assess rateable values varies depending on the type of property. The Valuation Office publishes a Rating Manual describing how each property class is valued. The manual for the 2023 rating list can be found here, and will be updated for the 2026 list in due course.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, published on 11 November 2025, what progress has she made in creating a preclinical translational models hub.

Reply

The delivery of the commitment to Create a preclinical translational models hub is led by the Medical Research Council (MRC).The Preclinical translational models hub funding call to identify a host for the hub was launched on 2 March 2026 with decisions on this expected in July. The Hub is expected to commence work this year.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Ministry of Defence·Answered
Asked

How much his Department has been asked to make in in-year budget savings in 2026/27.

Reply

As part of routine financial management, the Ministry of Defence continues to allocate resources effectively to meet departmental and operational priorities. The total Ministry of Defence budget this financial year stands at £65.5 billion.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, Published on 11 November 2025, what progress has she made in providing foundational 3Rs training in alternative methods to all PhD students and early career scientists.

Reply

The delivery of the commitment to provide foundational 3Rs training is led by the NC3Rs. NC3Rs is developing plans in collaboration with their Board on how to expand their existing PhD student and early career researcher training so that it is accessible to all scientists who are embarking on careers using animals and alternative methods.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Ministry of Defence·Answered
Asked

Pursuant to the Answer of 13 April 2026 to Question 123462 on Sky Sabre, what defence capability Land Ceptor is configured for.

Reply

The Common Anti-air Modular Missiles (CAMM) in use with the British Army are deployed from Land Ceptor launchers as part of the Sky Sabre air defence missile system. This provides short-medium range air defence against a spectrum of conventional threats including cruise missiles, fixed wing, rotary wing and uncrewed aerial systems.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, published on 11 November 2025, what progress has she made in creating positive incentives for research proposal applicants to develop and implement alternatives to animal use.

Reply

The delivery of the commitment to Enable funders to ensure thorough scrutiny of animal research in funding decisions is led by UKRI and will create positive incentives for research proposal applicants to develop and implement alternatives to animal use.UKRI are developing a funding service to support this and the strategy commits to start the funding cycle in 2026.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, published on 11 November 2025, what progress has she made in strengthening the commitment of journal editors to publishing research using alternative methods without requiring comparison with an animal model.

Reply

The delivery of the commitment to strengthen the commitment of journal editors to publishing research using alternative methods sits with NC3Rs.As set out in the strategy, this work will be initiated at the start of 2027. To support this, NC3Rs will launch their DRIVER (Designing and Reporting In Vitro Experiments Responsibly) recommendations that underpin improved experimental design and reporting of in vitro studies in 2026.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Ministry of Defence·Answered
Asked

How much was saved by his Department in-year savings in 2025/26.

Reply

As part of routine financial management, the Ministry of Defence continues to allocate resources effectively to meet departmental and operational priorities.The Department's final position for 2025-26 will be set out in the Annual Report and Accounts.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the policy paper Replacing animals in science: a strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, by how much she plans to increase investment in alternative methods in a) 2026/27, b) 2027/28 and c) 2028/29.

Reply

The commitments to increase investment and expand challenge led innovation for alternative methods are being led by UKRI.The Strategy was supported by £75m of funding and commits to increasing investment in alternative methods. UKRI has been in discussion to consider the most effective delivery approach and £20 million of increased funding is already available through the Pre‑clinical Translational Models Hub funding call, launched in March 2026. In addition, Innovate UK launched a £2 million Contracts for Innovation competition in February 2026.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, published on 11 November 2025, what progress she has made in developing a set of key performance indicators with which to assess delivery of the strategy.

Reply

The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Home Office·Answered
Asked

Pursuant to the answer of 15 April 2026, to question 125325 on Animal Welfare: Inspections, what is the number of animals used annually by MBR Acres.

Reply

The Home Office publishes annual statistics on the use of animals in science which contain information on the number of procedures conducted, including breakdowns by species of animals. The statistics report both the total number of procedures conducted and the number of animals used for the first time in a given year. Data is collected and published on an annual basis and is not disaggregated by establishment.The Animals (Scientific Procedures) Act 1986 (ASPA) requires establishments that breed or supply animals for use in scientific procedures to be licensed and regulated, even where no scientific procedures are carried out on site.MBR Acres Ltd is a breeding facility and does not carry out onsite testing.

15 Apr 2026·Department for Science, Innovation and Technology·Answered
Asked

Innovation and Technology, with reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, published on 11 November 2025, what progress has she made in increasing the visibility of available alternative methods to facilitate their uptake.

Reply

Work to increase the visibility of available alternative methods to facilitate their uptake will be led by the NC3Rs and delivered through an expansion of their gateway publishing platform, so that it is available to all researchers developing alternative methods. Work is underway to identify and collate UKRI-funded alternative methods for inclusion on the gateway. The strategy aims for this expanded platform to be in place by the end of 2026.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Home Office·Answered
Asked

With reference to the Policy paper: “Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods”, Published on 11 November 2025, what progress has she made in implementing the full recommendations of the Rawle Report.

Reply

The Home Office is working with the Animals in Science Regulation Unit, funders and wider stakeholders to progress implementation of the Rawle report recommendations. Specifically, the Animals in Science Committee, a ministerial advisory body, has been commissioned for advice on leading practice in delivery of the responsibilities of Animal Welfare and Ethical Review Bodies (AWERBs); addressing a key finding from the Rawle report.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy, later in 2026.

15 Apr 2026·Home Office·Answered
Asked

What progress the Animals in Science Regulation Unit has made in its (a) Regulatory Reform programme and (b) new target operating model.

Reply

The Animals in Science Regulation Unit (ASRU) launched its new organisational design and operating model in late 2025. This included increasing the size of the inspectorate from an average of 14.5 full-time equivalent (FTE) posts in 2023 to 22 FTE in 2026, strengthening the Regulator’s ability to scrutinise, monitor and assure compliance of regulated establishments with the Animals (Scientific Procedures) Act 1986. ASRU has also introduced specialist roles and functions to strengthen data analysis, quality monitoring and overall regulatory performance.The Government will publish a delivery update, alongside key performance indicators on progress across all elements of the strategy ‘Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods’, later in 2026.

15 Apr 2026·Ministry of Defence·Answered
Asked

Pursuant to the answer of 13 April 2026 to Question 123069 on Type 83 Destroyers: Procurement, when the concept phase of the Future Air Dominance System (a) started and (b) is due to be completed.

Reply

I refer the hon Member to my response to question 106653.

14 Apr 2026·Treasury·Answered
Asked

What assessment she has made of the potential a) merits of extending the R&D Expenditure Credit to include capital expenditure and the b) impact of that measure on allowing start-ups and pre-profit companies to invest and scale in the UK.

Reply

At Autumn Budget 2024, the Government made a number of commitments on R&D tax reliefs as part of the Corporate Tax Roadmap to provide the stability and certainty that help support investment decisions. The Government committed to maintaining the generosity of the rates in both the merged R&D Expenditure Credit (RDEC) scheme and the Enhanced R&D Intensive Support (ERIS). This, combined with the commitment to cap the headline rate of Corporation Tax, means that companies doing qualifying R&D will continue to receive between £15 to £27 for every £100 spent on R&D. The RDEC rate of 20 per cent represents the joint highest uncapped headline rate of R&D tax relief in the G7 for large companies, and the ERIS scheme will provide around £1.3 billion per year to eligible R&D-intensive, loss-making SMEs. Overall, R&D reliefs will support an estimated £56 billion of business R&D expenditure in 2029/30, roughly a 20 per cent increase from £47 billion in 2022/23. Companies are not currently able to claim R&D reliefs on capital expenditure, but the Government keeps the whole tax system under review.

14 Apr 2026·Home Office·Answered
Asked

With reference to her oral response to the hon. Member for Huntingdon on 5 January 2026, Official Report, column 25, by what date she will write to the hon. Member for Huntingdon.

Reply

A letter to the hon. Gentleman was sent on 28 April.

14 Apr 2026·Ministry of Defence·Answered
Asked

Pursuant to the answer of 27 March 2026 to question 122290 on Ajax Vehicles, what recent assessment he has made of the suitability of SPz Puma to replace Ajax.

Reply

Work on Ajax is ongoing. As I have previously updated the House, we have commissioned a number of safety reports. These have now been received, and we are working through their findings. I will update the House shortly on progress, as I have done since Exercise Titan Storm.

← PreviousPage 17 of 227Next →
Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.